Elixophyllin
NDC Package 17856-0644-2
Package Information
Elixophyllin is theophylline is used to treat lung diseases such as asthma and COPD (bronchitis, emphysema). Marketed by Atlantic Biologicals Corps, this product is identified by NDC 17856-0644 and is authorized under FDA application ANDA085186.
Identification & Billing
- RxCUI: 313306 - theophylline 80 MG in 15 mL Oral Solution
- RxCUI: 313306 - theophylline 5.33 MG/ML Oral Solution
- RxCUI: 313306 - theophylline 100 MG per 18.75 ML Oral Solution
- RxCUI: 313306 - theophylline 80 MG per 15 ML Oral Solution
- RxCUI: 756226 - Elixophyllin 80 MG in 15 mL Elixir
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 17856 - Atlantic Biologicals Corps
- 17856-0644 - Elixophyllin
- 17856-0644-2 - 18.75 mL in 1 CUP
- 17856-0644 - Elixophyllin
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (17856-0644). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 17856-0644-2 identifies a specific commercial package of 18.75 ml in 1 cup of Elixophyllin, labeled by Atlantic Biologicals Corps. This product is billed per "ML" milliliter and contains an estimated amount of 18.75 billable units per package. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Atlantic Biologicals Corps on October 01, 2009. The current certification is valid through December 31, 2018.
What are the primary indications for this medication?
Theophylline is used to treat lung diseases such as asthma and COPD (bronchitis, emphysema). It must be used regularly to prevent wheezing and shortness of breath. This medication belongs to a class of drugs known as xanthines. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. It also decreases the lungs' response to irritants. Controlling symptoms of breathing problems can decrease time lost from work or school. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden breathing problems. If sudden shortness of breath occurs, use your quick-relief inhaler as prescribed.
How is this Atlantic Biologicals Corps product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 17856064402. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 18.75 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.
